Exploring beetroot (<i>Beta vulgaris</i> L.) for diabetes mellitus and Alzheimer's disease dual therapy: <i>in vitro</i> and computational studies-Reference-Cited by-同舟云学术

Exploring beetroot (Beta vulgaris L.) for diabetes mellitus and Alzheimer's disease dual therapy: in vitro and computational studies

Published:2024 Issue:27 Volume:14 Page:19362-19380
ISSN:2046-2069
Container-title:RSC Advances
language:en
Short-container-title:RSC Adv.

Author:

Ojo Oluwafemi Adeleke¹²^ORCID,Gyebi Gideon Ampoma³^ORCID,Ezenabor Emmanuel Henry¹,Iyobhebhe Matthew⁴,Emmanuel Damilola Abigael¹,Adelowo Oluwatumininu Adetoro¹,Olujinmi Faith Eniola⁵,Ogunwale Temitope Emmanuel⁶,Babatunde Dare Ezekiel⁷,Ogunlakin Akingbolabo Daniel¹²,Ojo Adebola Busola⁸^ORCID,Adeyemi Oluyomi Stephen¹²

Affiliation:

1. Biochemistry Programme, Bowen University, Iwo 232102, Nigeria

2. Good Health and Wellbeing Research Clusters (SDG 03) Bowen University, Iwo 232102, Nigeria

3. Natural Products and Structural (Bio-Chem)-Informatics Research Laboratory (NpsBC-RI), Department of Biochemistry, Bingham University, Karu, Nigeria

4. Department of Biochemistry, Landmark University, Omu-Aran, Nigeria

5. Chemistry and Industrial Chemistry Programme, Bowen University, Iwo 232102, Nigeria

6. Agriculture Programme, Bowen University, Iwo 232102, Nigeria

7. Anatomy Programme, Bowen University, Iwo 232102, Nigeria

8. Department of Biochemistry, Ekiti State University, Ado-Ekiti, Nigeria

Abstract

This study explored the flavonoid-rich extract of beetroot (Beta vulgaris L.) for type 2 diabetes mellitus (T2D) and Alzheimer's disease (AD) dual therapy by using in vitro and molecular simulation studies.

Publisher

Royal Society of Chemistry (RSC)

Link

http://pubs.rsc.org/en/content/articlepdf/2024/RA/D4RA03638G

Reference56 articles.

1. The Effects of Momordica charantia on Type 2 Diabetes Mellitus and Alzheimer’s Disease

2. The International Diabetes Federation’s guide for diabetes epidemiological studies

3. Pancreatic β cell microRNA-26a alleviates type 2 diabetes by improving peripheral insulin sensitivity and preserving β cell function

4. Management of type 2 diabetes: evolving strategies for the treatment of patients with type 2 diabetes

5. GBD 2019 Dementia Forecasting Collaborators , The Lancet Public Health , 10.1016/s2468-2667(21)00249-8